Insider Trading activities of Neurocrine Biosciences Inc (NBIX)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Neurocrine Biosciences Inc (NBIX) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Neurocrine Biosciences Inc since year 2005. Table 2 shows the detailed insider transactions of Neurocrine Biosciences Inc since 2005. The reporting company's ticker symbol is NBIX. The reporting company's CIK number is 914475.
The total value of stock buying since 2005 is $10,350,601.
The total value of stock sales since 2005 is $226,900,282.
The total value of stock option exercises since 2005 is $31,861,387.


 1   2   3 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Neurocrine Biosciences Inc (NBIX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-10 0 $0 10,943 $991,890 9,956 $153,820
2019-09 0 $0 6,736 $673,600 6,736 $222,220
2019-08 0 $0 83,264 $7,951,528 86,295 $900,469
2019-07 0 $0 173,922 $15,924,163 148,087 $4,877,780
2019-06 0 $0 22,803 $1,910,048 22,803 $590,545
2019-05 0 $0 140,954 $11,219,765 139,297 $2,211,761
2019-02 0 $0 29,387 $2,551,940 0 $0
2019-01 0 $0 1,857 $156,158 0 $0
2018-12 0 $0 1,178 $106,020 0 $0
2018-11 0 $0 107,361 $11,775,379 84,114 $1,286,199
2018-10 0 $0 5,500 $589,237 0 $0
2018-09 0 $0 0 $0 32,749 $572,223
2018-08 0 $0 51,288 $5,783,010 51,288 $695,783
2018-06 0 $0 147,313 $14,759,666 167,887 $2,570,111
2018-05 0 $0 131,832 $10,657,309 156,832 $942,052
2018-04 0 $0 0 $0 30,000 $211,500
2018-03 0 $0 101,502 $9,132,160 101,502 $2,099,378
2018-02 0 $0 215,835 $17,228,753 188,347 $1,359,864
2018-01 0 $0 39,938 $3,233,782 40,063 $456,315
2017-12 0 $0 34,471 $2,564,737 24,471 $444,147
2017-11 0 $0 117,535 $8,405,514 87,535 $851,615
2017-10 0 $0 6,925 $422,702 6,925 $59,901
2017-09 0 $0 124,560 $7,341,557 124,560 $1,222,507
2017-08 0 $0 42,854 $2,244,470 65,354 $503,639
2017-07 0 $0 8,734 $436,700 8,734 $75,549
2017-05 0 $0 187,333 $10,020,224 192,333 $1,243,135
2017-04 0 $0 97,986 $4,979,646 20,000 $68,000
2017-02 0 $0 31,345 $1,337,611 119,161 $322,426
2017-01 0 $0 23,875 $1,002,086 0 $0
2016-12 0 $0 0 $0 9,100 $23,569
2016-11 0 $0 25,000 $1,321,000 0 $0
2016-09 0 $0 9,000 $450,000 9,000 $139,050
2016-08 0 $0 17,500 $851,825 0 $0
2016-05 0 $0 52,500 $2,450,800 45,000 $138,150
2016-04 0 $0 66,770 $2,953,272 56,770 $286,645
2016-02 0 $0 10,250 $389,852 20,000 $61,400
2016-01 0 $0 23,875 $1,086,325 0 $0
2015-11 0 $0 33,761 $1,832,432 33,761 $488,862
2015-10 0 $0 158,500 $7,572,295 0 $0
2015-09 0 $0 15,000 $822,450 0 $0
2015-07 0 $0 90,896 $4,799,280 90,896 $523,560
2015-06 0 $0 143,230 $6,379,973 143,230 $587,710
2015-05 0 $0 0 $0 15,000 $71,400
2015-04 0 $0 0 $0 45,000 $214,200
2015-03 0 $0 110,000 $4,686,700 80,000 $207,200
2015-02 0 $0 40,000 $1,500,000 47,500 $266,100
2015-01 0 $0 276,875 $7,802,751 260,500 $910,269
2014-12 0 $0 251,000 $5,719,032 271,000 $963,877
2014-11 0 $0 50,000 $964,076 0 $0
2014-10 0 $0 31,275 $575,962 0 $0
2014-09 0 $0 20,000 $313,200 0 $0
2014-05 0 $0 0 $0 24,000 $296,880
2014-04 0 $0 0 $0 39,000 $482,430
2014-03 0 $0 0 $0 85,000 $933,300
2014-01 0 $0 299,750 $5,257,490 50,000 $192,750
2013-09 0 $0 7,400 $117,464 0 $0
2013-08 0 $0 86,531 $1,299,574 0 $0
2013-07 0 $0 5,000 $72,500 0 $0
2013-06 0 $0 151,674 $1,921,958 0 $0
2013-03 0 $0 0 $0 63,000 $667,800
2012-12 0 $0 900 $6,669 0 $0
2011-10 103,400 $589,160 0 $0 0 $0
2011-02 0 $0 77,000 $525,602 0 $0
2010-04 0 $0 198,000 $550,660 0 $0
2010-03 0 $0 789,384 $2,128,562 0 $0
2010-01 0 $0 30,596 $77,702 0 $0
2009-11 900 $1,953 0 $0 0 $0
2009-09 0 $0 11,539 $35,930 0 $0
2009-03 0 $0 76,911 $263,660 0 $0
2009-01 123,500 $380,008 29,778 $99,593 0 $0
2008-12 110,000 $262,772 0 $0 0 $0
2008-11 54,400 $133,225 0 $0 0 $0
2008-10 447,047 $1,215,967 0 $0 0 $0
2008-09 0 $0 11,459 $53,804 0 $0
2008-07 156,800 $662,245 0 $0 0 $0
2008-05 179,700 $834,604 6,485 $32,749 0 $0
2008-03 890,700 $4,399,102 0 $0 0 $0
2008-02 384,200 $1,871,565 35,344 $178,376 0 $0
2007-04 0 $0 0 $0 63,091 $465,296
2006-05 0 $0 115,481 $2,306,963 0 $0
2006-03 0 $0 10,000 $700,130 0 $0
2005-12 0 $0 18,000 $1,148,547 0 $0
2005-11 0 $0 40,000 $2,314,219 0 $0
2005-10 0 $0 10,000 $515,000 0 $0
2005-09 0 $0 20,000 $990,000 0 $0
2005-08 0 $0 5,000 $233,750 0 $0
2005-06 0 $0 5,000 $198,500 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Neurocrine Biosciences Inc insiders (NBIX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-10-14 Lloyd-smith Malcolm (Chief Regulatory Officer) Sale 9,956 90.85 904,482
2019-10-14 Lloyd-smith Malcolm (Chief Regulatory Officer) Option Ex 9,956 15.45 153,820
2019-10-02 Cooke Julie (Chief Human Resources Officer) Sale 987 88.56 87,408
2019-09-03 Lippoldt Darin (Chief Legal Officer) Sale 6,736 100.00 673,600
2019-09-03 Lippoldt Darin (Chief Legal Officer) Option Ex 6,736 32.99 222,220
2019-08-27 Lippoldt Darin (Chief Legal Officer) Sale 1,600 100.00 160,000
2019-08-27 Lippoldt Darin (Chief Legal Officer) Option Ex 1,600 32.99 52,784
2019-08-23 Lippoldt Darin (Chief Legal Officer) Sale 1,664 100.09 166,554
2019-08-23 Lippoldt Darin (Chief Legal Officer) Option Ex 1,664 32.99 54,895
2019-08-09 Gorman Kevin Charles (Chief Executive Officer) Option Ex 3,031 32.99 99,992
2019-08-08 Gorman Kevin Charles (Chief Executive Officer) Sale 26,330 95.64 2,518,148
2019-08-08 Gorman Kevin Charles (Chief Executive Officer) Option Ex 26,330 8.66 228,017
2019-08-07 Gorman Kevin Charles (Chief Executive Officer) Sale 2,759 95.12 262,441
2019-08-07 Gorman Kevin Charles (Chief Executive Officer) Option Ex 2,759 8.66 23,892
2019-08-06 Gorman Kevin Charles (Chief Executive Officer) Sale 50,911 95.15 4,844,385
2019-08-06 Gorman Kevin Charles (Chief Executive Officer) Option Ex 50,911 8.66 440,889
2019-07-30 Lippoldt Darin (Chief Legal Officer) Sale 15,831 92.13 1,458,573
2019-07-30 Lippoldt Darin (Chief Legal Officer) Option Ex 15,831 18.15 287,332
2019-07-30 Grigoriadis Dimitri E. (Chief Research Officer) Sale 60,000 93.48 5,608,740
2019-07-30 Grigoriadis Dimitri E. (Chief Research Officer) Option Ex 50,000 32.99 1,649,500
2019-07-30 Bozigian Haig P. (Chief Development Officer) Sale 44,356 92.63 4,108,740
2019-07-30 Bozigian Haig P. (Chief Development Officer) Option Ex 44,356 38.12 1,690,628
2019-07-30 Lyons Gary A (Director) Sale 10,000 92.07 920,690
2019-07-15 Benevich Eric (Chief Commercial Officer) Sale 5,835 87.44 510,200
2019-07-15 Bozigian Haig P. (Chief Development Officer) Sale 30,680 87.50 2,684,500
2019-07-15 Bozigian Haig P. (Chief Development Officer) Option Ex 30,680 32.99 1,012,133
2019-07-11 Bozigian Haig P. (Chief Development Officer) Sale 100 87.59 8,759
2019-07-11 Bozigian Haig P. (Chief Development Officer) Option Ex 100 32.99 3,299
2019-07-10 Bozigian Haig P. (Chief Development Officer) Sale 7,120 87.64 623,961
2019-07-10 Bozigian Haig P. (Chief Development Officer) Option Ex 7,120 32.99 234,888
2019-06-18 Bozigian Haig P. (Chief Development Officer) Sale 2,100 87.82 184,415
2019-06-18 Bozigian Haig P. (Chief Development Officer) Option Ex 2,100 32.99 69,279
2019-06-13 Bozigian Haig P. (Chief Development Officer) Sale 17,268 82.92 1,431,914
2019-06-13 Bozigian Haig P. (Chief Development Officer) Option Ex 17,268 26.29 453,975
2019-06-03 Bozigian Haig P. (Chief Development Officer) Sale 3,435 85.51 293,719
2019-06-03 Bozigian Haig P. (Chief Development Officer) Option Ex 3,435 19.59 67,291
2019-05-31 Bozigian Haig P. (Chief Development Officer) Sale 19,297 85.02 1,640,573
2019-05-31 Bozigian Haig P. (Chief Development Officer) Option Ex 19,297 19.59 378,028
2019-05-24 Bozigian Haig P. (Chief Development Officer) Sale 17,486 80.03 1,399,439
2019-05-24 Bozigian Haig P. (Chief Development Officer) Option Ex 17,486 19.59 342,550
2019-05-22 Bozigian Haig P. (Chief Development Officer) Sale 1,300 80.03 104,037
2019-05-22 Bozigian Haig P. (Chief Development Officer) Option Ex 1,300 19.59 25,467
2019-05-16 Bozigian Haig P. (Chief Development Officer) Sale 66,667 80.13 5,341,893
2019-05-16 Bozigian Haig P. (Chief Development Officer) Option Ex 66,667 17.50 1,166,539
2019-05-13 Grigoriadis Dimitri E. (Chief Research Officer) Sale 1,657 75.44 125,007
2019-05-13 Bozigian Haig P. (Chief Development Officer) Sale 34,547 75.52 2,608,816
2019-05-13 Bozigian Haig P. (Chief Development Officer) Option Ex 34,547 8.66 299,177
2019-02-06 Benevich Eric (Chief Commercial Officer) Sale 920 83.57 76,883
2019-02-06 Gano Kyle (Chief Business Development Officer) Sale 762 83.56 63,672
2019-02-06 Lloyd-smith Malcolm (Chief Regulatory Officer) Sale 920 83.58 76,893
2019-02-06 Lippoldt Darin (Chief Legal Officer) Sale 791 83.52 66,063
2019-02-06 Grigoriadis Dimitri E. (Chief Research Officer) Sale 531 84.03 44,621
2019-02-06 Bozigian Haig P. (Chief Development Officer) Sale 920 83.54 76,859
2019-02-06 Gorman Kevin Charles (Chief Executive Officer) Sale 4,096 84.22 344,985
2019-02-05 Benevich Eric (Chief Commercial Officer) Sale 1,357 88.02 119,436
2019-02-05 Gano Kyle (Chief Business Development Officer) Sale 2,434 88.11 214,452
2019-02-05 Lloyd-smith Malcolm (Chief Regulatory Officer) Sale 1,272 88.14 112,117
2019-02-05 Lippoldt Darin (Chief Legal Officer) Sale 1,225 88.09 107,913
2019-02-05 Grigoriadis Dimitri E. (Chief Research Officer) Sale 1,070 88.17 94,338
2019-02-05 Bozigian Haig P. (Chief Development Officer) Sale 1,350 88.12 118,962
2019-02-05 Gorman Kevin Charles (Chief Executive Officer) Sale 4,489 88.20 395,934
2019-02-04 Gano Kyle (Chief Business Development Officer) Sale 1,375 88.14 121,187
2019-02-04 Grigoriadis Dimitri E. (Chief Research Officer) Sale 1,375 88.12 121,166
2019-02-04 Bozigian Haig P. (Chief Development Officer) Sale 1,375 88.10 121,138
2019-02-04 Gorman Kevin Charles (Chief Executive Officer) Sale 3,125 88.10 275,321
2019-01-08 Roberts Eiry (Chief Medical Officer) Sale 1,857 84.09 156,158
2018-12-03 Abernethy Matt (Chief Financial Officer) Sale 1,178 90.00 106,020
2018-11-26 Pops Richard F (Director) Sale 4,124 91.36 376,789
2018-11-12 Pops Richard F (Director) Sale 4,123 103.30 425,893
2018-11-08 Bozigian Haig P. (Chief Development Officer) Sale 36,295 110.00 3,992,450
2018-11-08 Bozigian Haig P. (Chief Development Officer) Option Ex 36,295 8.65 314,133
2018-11-07 Lloyd-smith Malcolm (Chief Regulatory Officer) Sale 3,300 110.00 363,000
2018-11-07 Lloyd-smith Malcolm (Chief Regulatory Officer) Option Ex 3,300 15.45 50,985
2018-11-07 Bozigian Haig P. (Chief Development Officer) Sale 29,399 110.10 3,236,771
2018-11-07 Bozigian Haig P. (Chief Development Officer) Option Ex 29,399 16.80 493,991
2018-11-06 Lloyd-smith Malcolm (Chief Regulatory Officer) Sale 5,700 110.02 627,096
2018-11-06 Lloyd-smith Malcolm (Chief Regulatory Officer) Option Ex 5,700 15.45 88,065
2018-11-06 Bozigian Haig P. (Chief Development Officer) Sale 9,420 110.10 1,037,170
2018-11-06 Bozigian Haig P. (Chief Development Officer) Option Ex 9,420 35.99 339,025
2018-11-02 Lyons Gary A (Director) Sale 15,000 114.41 1,716,210
2018-10-29 Pops Richard F (Director) Sale 5,500 107.13 589,237
2018-09-04 Grigoriadis Dimitri E. (Chief Research Officer) Option Ex 32,749 17.47 572,223
2018-08-01 Gano Kyle (Chief Business Development Officer) Sale 28,266 115.00 3,250,590
2018-08-01 Gano Kyle (Chief Business Development Officer) Option Ex 28,266 8.66 244,783
2018-08-01 Grigoriadis Dimitri E. (Chief Research Officer) Sale 23,022 110.00 2,532,420
2018-08-01 Grigoriadis Dimitri E. (Chief Research Officer) Option Ex 23,022 19.59 451,000
2018-06-28 Gorman Kevin Charles (Chief Executive Officer) Option Ex 57,924 15.13 876,390
2018-06-20 Grigoriadis Dimitri E. (Chief Research Officer) Sale 23,000 105.00 2,415,000
2018-06-20 Grigoriadis Dimitri E. (Chief Research Officer) Option Ex 23,000 19.59 450,570
2018-06-14 Grigoriadis Dimitri E. (Chief Research Officer) Sale 2,785 100.00 278,500
2018-06-14 Grigoriadis Dimitri E. (Chief Research Officer) Option Ex 2,785 19.59 54,558
2018-06-13 Grigoriadis Dimitri E. (Chief Research Officer) Sale 84,178 99.68 8,391,031
2018-06-13 Grigoriadis Dimitri E. (Chief Research Officer) Option Ex 84,178 14.12 1,188,593
2018-06-13 Lyons Gary A (Director) Sale 15,000 99.24 1,488,555
2018-06-11 Sherwin Stephen A (Director) Sale 10,000 98.44 984,419
2018-06-01 Benevich Eric (Chief Commercial Officer) Sale 12,350 97.34 1,202,161
2018-05-07 Nevinny Corinne H (Director) Sale 5,000 83.12 415,625
2018-05-02 Nevinny Corinne H (Director) Option Ex 15,000 7.05 105,750
2018-05-01 Gorman Kevin Charles (Chief Executive Officer) Sale 126,832 80.75 10,241,684
2018-05-01 Gorman Kevin Charles (Chief Executive Officer) Option Ex 126,832 5.76 730,552
2018-05-01 Pops Richard F (Director) Option Ex 15,000 7.05 105,750
2018-04-26 Sherwin Stephen A (Director) Option Ex 15,000 7.05 105,750
2018-04-03 Lyons Gary A (Director) Option Ex 15,000 7.05 105,750
2018-03-05 Gano Kyle (Chief Business Development Officer) Sale 23,650 90.00 2,128,500
2018-03-05 Gano Kyle (Chief Business Development Officer) Option Ex 23,650 8.65 204,572
2018-03-05 Lippoldt Darin (Chief Legal Officer) Sale 1,979 88.47 175,090
2018-03-05 Lippoldt Darin (Chief Legal Officer) Option Ex 1,979 18.15 35,918
2018-03-05 Bozigian Haig P. (Chief Development Officer) Sale 75,873 90.00 6,828,570
2018-03-05 Bozigian Haig P. (Chief Development Officer) Option Ex 75,873 24.50 1,858,888
2018-02-15 Lyons Gary A (Director) Sale 5,000 84.67 423,340
2018-02-12 Grigoriadis Dimitri E. (Chief Research Officer) Sale 14,593 80.00 1,167,454
2018-02-12 Grigoriadis Dimitri E. (Chief Research Officer) Option Ex 14,593 8.66 126,375
2018-02-09 Grigoriadis Dimitri E. (Chief Research Officer) Sale 71,775 77.98 5,596,727
2018-02-09 Grigoriadis Dimitri E. (Chief Research Officer) Option Ex 71,775 8.66 621,571
2018-02-06 Gorman Kevin Charles (Chief Executive Officer) Sale 100,000 80.07 8,006,600
2018-02-06 Gorman Kevin Charles (Chief Executive Officer) Option Ex 100,000 5.76 576,000
2018-02-05 Benevich Eric (Chief Commercial Officer) Sale 820 83.14 68,173
2018-02-05 Gano Kyle (Chief Business Development Officer) Sale 2,046 83.08 169,987
2018-02-05 Lloyd-smith Malcolm (Chief Regulatory Officer) Sale 960 83.19 79,862
2018-02-05 Lippoldt Darin (Chief Legal Officer) Sale 2,737 83.12 227,504
2018-02-05 Lippoldt Darin (Chief Legal Officer) Option Ex 1,979 18.15 35,918
2018-02-05 Grigoriadis Dimitri E. (Chief Research Officer) Sale 2,046 83.12 170,071
2018-02-05 Bozigian Haig P. (Chief Development Officer) Sale 2,262 83.12 188,026
2018-02-05 Obrien Christopher Flint (Former Chief Medical Officer) Sale 2,613 83.20 217,414
2018-02-05 Gorman Kevin Charles (Chief Executive Officer) Sale 5,983 83.27 498,216
2018-02-05 Lyons Gary A (Director) Sale 5,000 83.08 415,379
2018-01-24 Rastetter William H (Director) Sale 9,500 90.00 855,000
2018-01-24 Rastetter William H (Director) Option Ex 20,000 7.05 141,000
2018-01-16 Gano Kyle (Chief Business Development Officer) Sale 1,625 79.05 128,459
2018-01-16 Grigoriadis Dimitri E. (Chief Research Officer) Sale 1,625 79.12 128,563
2018-01-16 Bozigian Haig P. (Chief Development Officer) Sale 1,625 79.12 128,574
2018-01-16 Obrien Christopher Flint (Chief Medical Officer) Sale 1,750 79.14 138,498
2018-01-16 Gorman Kevin Charles (Chief Executive Officer) Sale 3,750 78.89 295,818
2018-01-03 Lippoldt Darin (Chief Legal Officer) Sale 1,979 79.36 157,053
2018-01-03 Lippoldt Darin (Chief Legal Officer) Option Ex 1,979 18.15 35,918
2018-01-02 Lloyd-smith Malcolm (Chief Regulatory Officer) Sale 18,084 77.52 1,401,817
2018-01-02 Lloyd-smith Malcolm (Chief Regulatory Officer) Option Ex 18,084 15.45 279,397
2017-12-28 Lippoldt Darin (Chief Legal Officer) Sale 15,237 75.00 1,142,775
2017-12-28 Lippoldt Darin (Chief Legal Officer) Option Ex 15,237 18.15 276,551
2017-12-08 Lippoldt Darin (Chief Legal Officer) Sale 2,955 75.00 221,625
2017-12-08 Lippoldt Darin (Chief Legal Officer) Option Ex 2,955 18.15 53,633
2017-12-04 Lippoldt Darin (Chief Legal Officer) Sale 6,279 75.04 471,157
2017-12-04 Lippoldt Darin (Chief Legal Officer) Option Ex 6,279 18.15 113,963
2017-12-01 Lyons Gary A (Director) Sale 10,000 72.92 729,180
2017-11-15 Lippoldt Darin (Chief Legal Officer) Sale 9,900 73.05 723,195
2017-11-15 Lippoldt Darin (Chief Legal Officer) Option Ex 9,900 18.15 179,685
2017-11-08 Grigoriadis Dimitri E. (Chief Research Officer) Sale 30,000 74.58 2,237,340
2017-11-02 Gano Kyle (Chief Business Development Officer) Sale 24,818 71.05 1,763,318
2017-11-02 Gano Kyle (Chief Business Development Officer) Option Ex 24,818 8.65 214,799
2017-11-02 Obrien Christopher Flint (Chief Medical Officer) Sale 52,817 69.71 3,681,661
 1   2   3 

Insider trading activities including stock purchases, stock sales, and option exercises of NBIX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Neurocrine Biosciences Inc (symbol NBIX, CIK number 914475) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month